Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced ...

J.P. Morgan analyst Doug Anmuth said he sees room for Alphabet, Google’s parent, to gain ground on a variety of fronts, ...

Carvana fell again Friday a day after short-seller Hindenburg Research criticized the used-car retailer in an extensive ...

Reaching more mUM patients globally with KIMMTRAK (tebentafusp) in 2025 through additional launches and increased community penetration Enrolling three Phase 3 trials across multiple melanoma ...

J.P. Morgan Asset Management’s Michael Cembalest calls them “Alchemists” — the Trump White House nominees who are looking to ...

The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health ...

In a report released on January 7, Jeremy Tonet from J.P. Morgan maintained a Buy rating on Constellation Energy Corporation (CEG – Research ...

In Ultragaz, the company has been strengthening its presence in the bulk market with associated solutions and better margins, ...

The banking giant has filed two lawsuits, one in Greece for €916m and one in the U.K., against WeRealize, in an ongoing legal dispute over their co-owned business, Viva Wallet.

Intuitive Surgical (ISRG), and Insulet (PODD) stocks were cited as top MedTech stock picks for 2025 by J.P. Morgan. Read more ...

J.P. Morgan analyst Mark Murphy maintained a Buy rating on Salesforce (CRM – Research Report) today and set a price target of $380.00. The ...